Rituximab is a laboratory manufactured antibody that targets the cells in our bodies that produce antibodies. This was genetically engineered and is the first monoclonal antibody to be approved by the FDA for the treatment of cancer. The current indication…
- Accueil
- Qui sommes-nous
- Vivant avec P/P
- Recherche
- Impliquez-vous
- Actualités & Info
- Forums de discussion
